{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:43:51Z","timestamp":1788525831035,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neurobiolaging.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T00:31:02Z","timestamp":1367541062000},"page":"2379-2388","source":"Crossref","is-referenced-by-count":42,"title":["Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice"],"prefix":"10.1016","volume":"34","author":[{"given":"Tina","family":"L\u00f6ffler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Flunkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Havas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"S\u00e1ntha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Hutter-Paier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Steyrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib1","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/pr7006329","article-title":"Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice","volume":"7","author":"Bereczki","year":"2008","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuint.2006.01.026","article-title":"Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis","volume":"49","author":"Bjelik","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib3","first-page":"381","article-title":"Atherosclerosis and oxidative stress","volume":"23","author":"Bonomini","year":"2008","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.272.5262.685","article-title":"Mouse models of atherosclerosis","volume":"272","author":"Breslow","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(02)09420-5","article-title":"Alzheimer's disease","volume":"360","author":"Burns","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib6","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.91.6.2130","article-title":"Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice","volume":"91","author":"Callow","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib7","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1172\/JCI118203","article-title":"Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a)","volume":"96","author":"Callow","year":"1995","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","article-title":"Cerebral microvascular pathology in aging and Alzheimer's disease","volume":"64","author":"Farkas","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib10","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1196\/annals.1354.065","article-title":"Alzheimer's disease pathogenesis: role of aging","volume":"1067","author":"Harman","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2011-101866","article-title":"A\u00a0longitudinal study of behavioral deficits in an AbetaPP transgenic mouse model of Alzheimer's disease","volume":"25","author":"Havas","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.exger.2010.11.032","article-title":"Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?","volume":"46","author":"Humpel","year":"2011","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.45.6.1092","article-title":"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study","volume":"45","author":"Jarvik","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0891-5849(00)00458-5","article-title":"Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma","volume":"30","author":"Kontush","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib18","first-page":"405","article-title":"[The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease]","volume":"38","author":"Kowalska","year":"2004","journal-title":"Neurologia i neurochirurgia polska"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/bbrc.1998.9652","article-title":"Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels","volume":"252","author":"Kuo","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib20","doi-asserted-by":"crossref","first-page":"e46007","DOI":"10.1371\/journal.pone.0046007","article-title":"Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice","volume":"7","author":"Lenart","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.20629","article-title":"Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment","volume":"58","author":"Markesbery","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","article-title":"Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease","volume":"111","author":"Martins","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1479-8301.2009.00294.x","article-title":"Vascular pathology in Alzheimer's disease","volume":"10","author":"Miyakawa","year":"2010","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jnr.1247","article-title":"Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1\u201342)","volume":"66","author":"Rockenstein","year":"2001","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"suppl 3","key":"10.1016\/j.neurobiolaging.2013.04.008_bib26","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/00002093-199912003-00016","article-title":"Vascular factors and Alzheimer disease","volume":"13","author":"Skoog","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L","article-title":"Link between heart disease, cholesterol, and Alzheimer's disease: a review","volume":"50","author":"Sparks","year":"2000","journal-title":"Microsc. Res. Techn."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.lfs.2009.04.011","article-title":"Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice","volume":"84","author":"Sule","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(01)00476-7","article-title":"New frontiers in Alzheimer's disease genetics","volume":"32","author":"Tanzi","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1042\/bst0300552","article-title":"Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition","volume":"30","author":"Walsh","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000070185.02546.5D","article-title":"Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia","volume":"61","author":"Yao","year":"2003","journal-title":"Neurology."},{"key":"10.1016\/j.neurobiolaging.2013.04.008_bib32","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1523\/JNEUROSCI.22-12-04833.2002","article-title":"A\u00a0novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage","volume":"22","author":"Zou","year":"2002","journal-title":"J.Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T09:31:49Z","timestamp":1563010309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0197458013001619"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.04.008","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}